UNIXELL
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
UNIXELL
Industry:
Biotechnology Medical
Founded:
2021-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
31.42 M USD
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
Investors List
Fosun Pharma
Fosun Pharma investment in Seed Round - UniXell
GL Ventures
GL Ventures investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Seed Round - UniXell
Sherpa Venture Capital
Sherpa Venture Capital investment in Seed Round - UniXell
Winfast Holding
Winfast Holding investment in Seed Round - UniXell
TF Capital
TF Capital investment in Seed Round - UniXell
CDH Investments
CDH Investments investment in Seed Round - UniXell
Kunlun Capital
Kunlun Capital investment in Angel Round - UniXell
GL Ventures
GL Ventures investment in Angel Round - UniXell